The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Try the newly designed Company Pages!
Switch now

Cyberonics Inc.

  • CYBX
  • NASDAQ
  • Consumer Products
  • Latest 50.27
  • Currency US$
  • Change -0.89
  • Percent Change -1.74 %
  • Volume 407,147
  • Wed Oct 1, 2014 04:00 PM EDT NASDAQ data delayed 15 minutes.
  • Open 51.01
  • Previous Close 51.16
  • High 51.06
  • Low 49.94
  • Bidx1 0.003
  • Askx10 52.00
  • 52-week High02/14 73.52
  • 52-week Low10/01 49.65
  • Beta 0.386
  • Market Cap 1,348.74M
  • EPS 2.19
  • P/E 22.954
  • Forward P/E 18.21
  • PEG 1.33
  • Annual Dividend 0.0000
  • Yield

News

Financials & Calendars

Income Statement

  • Sales $282,010,000
  • Earnings $54,890,000
  • Return on Equity 21.99%

Cash Flow

  • Cash Flow --
  • Cash $103,290,000
  • Current Ratio 7.37

12 months ended Apr 30, 2014.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $294,190,000
  • Liabilities $35,090,000
  • Liabilities-to-Equity Ratio 0.14

Price Ratios

  • Price to Sales 4.78
  • Price to Book 5.21
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings Aug 21 $0.56 Nov 20 $0.59
Surprises Aug 21 -5.36% n/a n/a
Dividends n/a n/a n/a n/a
Splits n/a -- n/a n/a

12 months ended Oct 01, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

Cyberonics, Inc. was founded to design, develop and market medical devices for the treatment of epilepsy and other debilitating neurological disorders using a therapy, vagus nerve stimulation. The company's initial target market is epilepsy, the world's second most prevalent neurological disorder, which is characterized by seizures. Vagus nerve stimulation with the Cyberonics NCP System was approved for use as an adjunctive therapy in reducing the frequency of seizures in adults and adolescents with medically refractory partial onset seizures. (PRESS RELEASE)

Related Securities
Symbol Type Latest % Chg

Officers

  • Hugh M. Morrison Chairman of the Board of Direc
  • Daniel J. Moore Chief Executive Officer; Direc
  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: United States,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

100 CYBERONICS BLVD
HOUSTON, TX
77058

Phone: (281)-228-7200
Fax: (281)-2189332

ir@cyberonics.com
www.cyberonics.com

Ideas & Discussion

Live Discussion of CYBX on StockTwits
The Globe and Mail has
updated our Company Pages
Switch to the newly designed Company Pages format today for a more in-depth look at the companies you're following and pages that are easier to navigate. If you prefer the old layout after trying the new Company Pages, you can switch back anytime.